4195 Stock Overview
Genomics BioSci & Tech. Co.,Ltd. operates as a genome sequencing company.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Genomics BioSci & Tech. Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$19.30 |
| 52 Week High | NT$26.08 |
| 52 Week Low | NT$17.60 |
| Beta | 0.26 |
| 1 Month Change | 1.58% |
| 3 Month Change | -7.21% |
| 1 Year Change | -2.79% |
| 3 Year Change | 23.19% |
| 5 Year Change | 25.50% |
| Change since IPO | -37.03% |
Recent News & Updates
Recent updates
Is Genomics BioSci & Tech. Co.,Ltd.'s (GTSM:4195) 7.2% Dividend Worth Your Time?
Apr 27
Key Things To Consider Before Buying Genomics BioSci & Tech. Co.,Ltd. (GTSM:4195) For Its Dividend
Jan 19
Genomics BioSci & Tech. Co.,Ltd. (GTSM:4195) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Nov 25Shareholder Returns
| 4195 | TW Biotechs | TW Market | |
|---|---|---|---|
| 7D | 7.5% | -1.6% | -2.3% |
| 1Y | -2.8% | -22.6% | 27.2% |
Return vs Industry: 4195 exceeded the TW Biotechs industry which returned -22.6% over the past year.
Return vs Market: 4195 underperformed the TW Market which returned 27.2% over the past year.
Price Volatility
| 4195 volatility | |
|---|---|
| 4195 Average Weekly Movement | 2.1% |
| Biotechs Industry Average Movement | 4.8% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in TW Market | 8.7% |
| 10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 4195 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4195's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Kevin Chiang | www.genomics.com.tw |
Genomics BioSci & Tech. Co.,Ltd. operates as a genome sequencing company. It offers regular DNA, complex sequence, and TAF certificated sequencing services, as well as free sequencing primer and primer walking services; peptide, gene, and oligo synthesis services; and sample preparation, gene expression analysis, genotyping analysis, DNA methylation analysis, and microbial identification services.
Genomics BioSci & Tech. Co.,Ltd. Fundamentals Summary
| 4195 fundamental statistics | |
|---|---|
| Market cap | NT$1.40b |
| Earnings (TTM) | -NT$168.07m |
| Revenue (TTM) | NT$396.14m |
3.5x
P/S Ratio-8.3x
P/E RatioIs 4195 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4195 income statement (TTM) | |
|---|---|
| Revenue | NT$396.14m |
| Cost of Revenue | NT$276.23m |
| Gross Profit | NT$119.91m |
| Other Expenses | NT$287.98m |
| Earnings | -NT$168.07m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.32 |
| Gross Margin | 30.27% |
| Net Profit Margin | -42.43% |
| Debt/Equity Ratio | 35.1% |
How did 4195 perform over the long term?
See historical performance and comparison